Report Overview:
The Global Prepared Food Market achieved a valuation of $148.67 Billion in 2022 and is anticipated to exceed $214.71 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 4.7% during the forecast period from 2024 to 2032.
Key Market Players:
Nestle, General Mills Inc., Kellogg Company, Conagra Brands Inc., Tyson Foods Inc., Dr. Oetker, Nomad Foods, Green Mill Foods, Unilever, 2 Sisters Food Group and others.
Report Overview:
The Global Food Truck Market achieved a valuation of $3.19 Billion in 2022 and is anticipated to exceed $5.25 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 6.4% during the forecast period from 2024 to 2032.
Key Market Players:
Prestige Food Trucks, United Food Trucks United LLC, M&R Trailers, VS VeicoliSpeciali, MRA, Futuristo Trailers, MSM Catering Trucks Manufacturing, The Fud Trailer Company, Food Truck Company B.V., Bostonian Body Inc. and others.
Report Overview:
The Global Noodles Market achieved a valuation of $16.54 Billion in 2022 and is anticipated to exceed $21.60 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 3.4% during the forecast period from 2024 to 2032.
Key Market Players:
Uni-President, Beltek Foods, Nestle, Mandarin Noodle, Sanyo Foods, Master Kong Maruchan, Nissin Foods, Indofood, Nong Shim and others.
Report Overview:
The Global mRNA Cancer Vaccines and Therapeutics Market achieved a valuation of $54.99 Billion in 2022 and is anticipated to exceed $193.14 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 17% during the forecast period from 2024 to 2032.
Key Market Players:
Moderna Therapeutics (US), eTheRNA (Belgium), BioNTech (Germany), CureVac (Netherlands), In-Cell-Art (France), Translate Bio (US), Tiba Biotechnology (US), Argos Therapeutics (US), Sangamo Therapeutics (US), and Ethris (Germany).
Report Overview:
The Global Plant Based Food Market achieved a valuation of $44.68 Billion in 2022 and is anticipated to exceed $108.30 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 11.7% during the forecast period from 2024 to 2032.
Key Market Players:
Amy's Kitchen Inc., Atlantic Natural Foods LLC, Beyond Meat Inc., Danone SA, Garden Protein International Inc., Impossible Foods Inc., Lightlife Foods Inc. (Maple Leaf Foods Inc.), Nestle S.A., Tyson Foods Inc., Vbite Food Ltd. and others.
Report Overview:
The Global Biobanking Market achieved a valuation of $29.30 Billion in 2022 and is anticipated to exceed $56.26 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 8.5% during the forecast period from 2024 to 2032.
Key Market Players:
Report Overview:
The Global Gene Panel Market achieved a valuation of $2.40 Billion in 2022 and is anticipated to exceed $10.34 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 20% during the forecast period from 2024 to 2032.
Key Market Players:
Thermo Fisher Scientific Inc., BGI, GENEWIZ, Inc., GATC Biotech, Novogene Co., Ltd., QIAGEN, Integrated DNA Technologies, Inc., Illumina Inc., Agilent Technologies, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, Personalis Inc., GeneDx Inc.,
Report Overview:
The Global Diagnostic Imaging Market achieved a valuation of $27685.42 Million in 2022 and is anticipated to exceed $42167.31 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 5.4% during the forecast period from 2024 to 2032.
Key Market Players:
Report Overview:
The Global VNA and PACS Market achieved a valuation of $3607.31 Million in 2022 and is anticipated to exceed $5411.39 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 5.2% during the forecast period from 2024 to 2032.
Key Market Players:
Report Overview:
The Global Lung in Vitro Model Market achieved a valuation of $275.1 Million in 2022 and is anticipated to exceed $976.1 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 17.1% during the forecast period from 2024 to 2032.
Key Market Players:
Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).
